Supervised Asthma Medication in Schools (SAMS)

• Status: Completed
• Trial end date: 2016-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that school-based, direct supervision of daily controller therapy will result in more effective asthma control, as assessed by the Asthma Control Questionnaire than usual care. Additionally, as the result of enhanced asthma control and resulting decrease in health care utilization, school-based, direct supervision of daily controller therapy will result in lower cost per quality-adjusted life year (QALY) gained than usual care.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Arizona
• Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Albuterol

Criteria

Inclusion Criteria:

• A child with asthma attending a Tucson Unified School District elementary school selected for the study.

Exclusion Criteria:

• No asthma.

• Not attending a Tucson Unified School District elementary school selected for the study.